Trials / Completed
CompletedNCT00714415
Registry For Patients Treated With BeneFix In Usual Care Setting In Germany
Pharmacovigilance Evaluation Of Benefix (Registered) In Germany And Austria
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational study is to describe the incidence of adverse events among patients treated with BeneFix® in usual health care settings in Germany.
Detailed description
Non-interventional study: subjects to be selected according to the usual clinical practice of their physician
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BeneFIX | Patients will be treated in accordance with the requirements of the labeling of BeneFIX in Germany. The dosage and duration of therapy is to be determined by the physician to meet the patients' individual needs for treatment. |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2008-07-14
- Last updated
- 2018-10-25
- Results posted
- 2018-09-24
Locations
21 sites across 2 countries: Austria, Germany
Source: ClinicalTrials.gov record NCT00714415. Inclusion in this directory is not an endorsement.